- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT05313737
Opt-in vs. Opt-out for Breast Cancer Screening
Opt-in vs. Opt-out Mammography Screening Outreach: a Randomized Controlled Trial
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
This is a prospective, randomized controlled trial that will evaluate the effectiveness of two different outreach strategies in improving adherence to breast cancer screening via mammography.
Average risk female Veterans who are due for breast cancer screening (defined as aged 45-75 with no previous history of bilateral mastectomy, not under hospice care, and alive at the time of screening) will be identified through administrative data.
Veterans eligible for enrollment into the trial will be randomized in a 1:1 allocation using permuted block randomization (with random block sizes of 2 and 4) to the following interventions:
Arm 1: Automated phone opt-in message Intervention Type: Audiocare message requiring Veteran to confirm that they would like to participate in screening and have consult sent Arm 2: Opt-out scheduling Intervention Type: Consult automatically sent and Veteran called to schedule screening
Randomization will be stratified within arms by prior screening status (prior screener vs. never screener).
The study's primary outcome of interest is screening completion at 100 days post randomization. The study's secondary outcome of interest is screening scheduling at 100 days post randomization. Subgroup analysis aim 1 will explore whether the differences in breast cancer screening completion between investigational groups varies according to the Veterans' race/ethnicity. Subgroup analysis aim 2 will explore whether the differences in breast cancer screening scheduling between investigational groups varies according to the Veterans' race/ethnicity. Enrollment in the trial will occur between March 1, 2022 and August 31, 2022.
Studietype
Registrering (Forventet)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Stefanie Deeds, MD
- Telefonnummer: 206-314-0507
- E-post: Stefanie.Deeds@va.gov
Studer Kontakt Backup
- Navn: Alaina Mori, MS
- Telefonnummer: 206-247-6782
- E-post: Alaina.Mori@va.gov
Studiesteder
-
-
Washington
-
Seattle, Washington, Forente stater, 98108
- VA Puget Sound Health Care System
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- female Veterans aged 45-75
- assigned to a primary care provider at the VA Puget Sound as of January 1, 2022 with at least 1 year of prior data available
- due for breast cancer screening (have not had a mammogram in the last 12 months)
Exclusion Criteria:
- must not be any indication of current receipt of hospice care
- no record of recent death in the administrative data
- not scheduled for either a screening or diagnostic mammogram within the following 12 weeks from assessment.
- not have a personal history of bilateral mastectomy.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Screening
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Trippel
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Automated phone opt-in message
Audiocare message requiring Veteran to confirm that they would like to participate in screening and have consult sent
|
Automated message via phone call (audiocare)
|
|
Eksperimentell: Opt-out scheduling
Consult automatically sent and Veteran called to schedule screening
|
Scheduling via non-automated phone call
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Percentage of mammograms completed at 100 days post randomization
Tidsramme: 100 days post randomization
|
Percent of mammograms completed
|
100 days post randomization
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Percentage of mammograms scheduled at 100 days post randomization
Tidsramme: 100 days post randomization
|
Percent of mammograms scheduled
|
100 days post randomization
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Percentage of mammograms cancelled at 100 days post randomization
Tidsramme: 100 days post randomization
|
Percent of mammograms cancelled
|
100 days post randomization
|
|
Percentage of mammograms active at 100 days post randomization
Tidsramme: 100 days post randomization
|
Percent of mammograms active
|
100 days post randomization
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Ashok Reddy, MD, VA Puget Sound Health Care System
- Hovedetterforsker: Stefanie Deeds, MD, VA Puget Sound Health Care System
Studierekorddatoer
Studer hoveddatoer
Studiestart (Forventet)
Primær fullføring (Forventet)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- MAMMoutreach
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .